Izvorni znanstveni članak

https://doi.org/10.20471/acc.2021.60.02.08

The Effect of Primary Argon Laser Trabeculoplasty on Intraocular Pressure Reduction and Quality of Life in Patients with Pseudoexfoliation Glaucoma

Dušan Todorović ; University of Kragujevac, Faculty of Medical Sciences, Department of Ophthalmology, Kragujevac, Serbia; Department of Ophthalmology, Kragujevac Clinical Center, Kragujevac, Serbia
Tatjana Šarenac Vulović ; University of Kragujevac, Faculty of Medical Sciences, Department of Ophthalmology, Kragujevac, Serbia; Department of Ophthalmology, Kragujevac Clinical Center, Kragujevac, Serbia
Sunčica Srećković ; University of Kragujevac, Faculty of Medical Sciences, Department of Ophthalmology, Kragujevac, Serbia; Department of Ophthalmology, Kragujevac Clinical Center, Kragujevac, Serbia
Svetlana Jovanović ; University of Kragujevac, Faculty of Medical Sciences, Department of Ophthalmology, Kragujevac, Serbia; Department of Ophthalmology, Kragujevac Clinical Center, Kragujevac, Serbia
Nenad Petrović ; University of Kragujevac, Faculty of Medical Sciences, Department of Ophthalmology, Kragujevac, Serbia; Department of Ophthalmology, Kragujevac Clinical Center, Kragujevac, Serbia

Sažetak

The aim of the study was to assess the impact of primary argon laser trabeculoplasty
(ALT) on intraocular pressure (IOP) lowering and quality of life improvement in patients with
pseudoexfoliative glaucoma. Sixty patients with newly diagnosed pseudoexfoliative glaucoma who
underwent primary ALT (group 2) or medication therapy (group 1) were followed-up. The effect of
ALT on IOP reduction, dry eye development and number of antiglaucoma drugs used was examined.
Patients were examined at the beginning of the study and then after 6, 12, and 18 months. A statistically
significant difference between IOP values was observed throughout the 18-month follow-up,
with the highest significance recorded 6 months after ALT (p=0.009). Twelve months after the start
of the study, the TBUT value was 6.0±0.8 s in group 1 and 8.4±0.7 s in group 2. In group 2, the value
of Schirmer test was constantly above 10 millimeters. The number of antiglaucoma medications used
in group 1 was statistically significantly higher as compared to group 2 throughout the 18-month
study period. ALT was found to be better choice for temporary regulation of IOP in patients with
pseudoexfoliative glaucoma.

Ključne riječi

Argon laser trabeculoplasty; Intraocular pressure; Antiglaucoma drugs

Hrčak ID:

263488

URI

https://hrcak.srce.hr/263488

Datum izdavanja:

1.6.2021.

Podaci na drugim jezicima: hrvatski

Posjeta: 944 *